Clinical Trials Logo

Clinical Trial Summary

It is recommended to screen ageing patients for sarcopenia, due to the increased risk of morbimortality if detected positive. According to the consensus of the European Working Group on Sarcopenia in Older People, the diagnosis of sarcopenia is based, among other things, on grip strength measurement. Our study will compare the performance of the new GRIPWISE digital device with the mechanical dynamometer JAMAR, the gold standard currently used to assess the grip strength. We propose to evaluate it in an elderly hospitalized population where the prevalence of sarcopenia is likely to be high due to the high prevalence of various chronic illness, notably oncological and cardiological ones. This cross-sectional study will include 348 patients.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05060874
Study type Observational
Source University Hospital, Caen
Contact François Fournel
Phone +33231065488
Email [email protected]
Status Recruiting
Phase
Start date September 1, 2021
Completion date November 30, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT04048616 - Impact of Protein and Alkali Supplementation on Skeletal Muscle in Older Adults N/A
Recruiting NCT04309292 - Protein and Skeletal Muscle in Older Twins: Role of the Gut Microbiome N/A